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Introduction 
Stem cells are primitive not specialized cells, able to regenerate 
themselves and to differentiate into specific cell types [1]. Accord-
ing to their differentiative ability, stem cells are classified in totipo-
tent (isolated by the first phases of  the embryo development until 
the eight-cell stage), able to give rise to all cell types of  the organ-
ism, including extra-embryonic tissues [1,2]; pluripotent, isolated 
from the inner cell mass of  the blastocyst and able to differenti-
ate into cell types derived from the three germ layers (endoderm, 
mesoderm and ectoderm) but not in extra-embryonic tissues [2]; 
multipotent (identified in the fetus and in the adult tissues), capa-
ble of  generating a limited number of  cell types, restricted to a 
single germ layer; unipotent, able to generate a single cell type [3]. 
According to the stage of  development of  the organism from 
which they are obtained, stem cells can also be classified in em-
bryonic and adult stem cells [1].
Embryonic stem cells (ESC), pluripotent, have a high grade of  
plasticity and self-renewal, with an important therapeutic poten-
tial, but may form tumors when injected and may determine host 
immune rejection . Moreover, their use opens a wide spectrum of  
ethical concerns [4]. Adult stem cells (ASC), multipotent, have a 
more limited differentiation and proliferative potential compared 
to ESC but do not present ethical problems. ASCs are naturally 
present in each organism during the whole life and their role is 
repairing tissues after injuries and replace old cells [1,2]. 
Among ASCs, mesenchymal stem cells (MSCs), multipotent, rep-
resent a promising tool in clinical applications for their differen-
tiative potential towards mesoderm-derived lineage (liver, kidney, 
muscle, epithelial, neuronal and cardiac cells) [5].  
The International Society for Cell Therapy (ISCT) proposed a set 
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of  standard criteria to identify MSCs: (a) plastic adherent ability; 
(b) expression of  CD73, CD90 and CD105 and lack the expres-
sion of  CD14, CD19, CD31,CD34,CD45 and HLA-DR surface 
molecules;(c) mesodermal differentiation capability into osteo-
blasts, chondrocytes and adipocytes and (d) immunomodulatory 
functions.
Considering this assumption it is possible to distinguish mesen-
chymal stem cells from other cells thanks to their fibroblastoid 
morphology and their ability to grow adherent to plastic in cul-
ture.
These cells can be easily detected through the assessment of  their 
immunophenotype and the absence of  positivity for all hemat-
opoietic markers (CD34,CD45,CD11b,CD33,CD117 and HLA-
DR). Investigators often use immunomagnetic beads or flow cit-
ometry to select this subpopulation of  cells [6].
In clinical practice, the main source of  MSCs is the adult bone 
marrow [7]. However, cultures of  mesenchymal cells derived 
from bone marrow is associated to several problems: it is a weak 
accessible source and it involves the use of  invasive techniques. 
The percentage of  MSCs in the bone marrow is very low (0.001-
0.01%) and it decreases with ageing. For these reasons it is im-
portant to find alternative sources of  MSCs [8], such as adipose 
tissue, peripheral blood or foetal tissues [5,9].
Adipose tissue is well distributed in the body and cells isolated 
form this source (Adipose Derived Mesenchymal Stem Cells, 
AD-MSCs) have the same characteristics as Bone Marrow de-
rived MSCs [10] as they are able to grow on plastic surface, they 
show fibroblastoid morphology, they are able to generate Colony 
Forming Units (CFU), they express typical MSCs markers and 
they are able to differentiate into adipocites, chondrocites and os-
teoblasts [11,12]. MSCs can be characterized by the expression of  
specific surface markers, like CD105, CD73 and CD90, or by the 
expression of  typical stem cell genes  which are OCT-4 (Octamer-
Binding Transcription Factor 4), NANOG and SOX2 (SRY box-
containing factor 2) [13].
AD-MSCs are a suitable choice for regenerative medicine because 
they can be used in authologous manner and they can be easily 
isolated in human and animals from subcutaneous adipose tissue 
to be harvested in vitro for different culture passages [14,15].
Selection of  appropriate animal models for preclinical evaluations 
is crucial for optimization and validation of  therapeutic protocols 
in regenerative medicine. For this reason, in vitro studies are neces-
sary to future in vivo MSC applications. For this study we chose 
Rat model, which is an established small animal model for a large 
number of  in vitro studies. 
Materials and Methods
Isolation of  MSCs from Adipose Tissue
Subcutaneous fat was obtained from 20 Wistar breed male rats 
whose average weight was 350g. All animals were sedated with an 
intramuscular injection of  midazolam and anesthesia was main-
tained with isoflurane and oxygen gas mixture administered with 
a mask. For adipose tissue procurement, a small incision of  about 
2 cm was performed at the root of  animal’s thigh. Through blunt 
dissection, the fat was separated from the muscular layer and fi-
nally, excised. The skin was closed with single interrupted stitches. 
Adipose tissue samples were carried to the laboratory into a sterile 
box containing HBSS (Hanks balanced salt solution; Gibco) sup-
plemented with 5% antibiotics. 
Following 1 hour of  tissue recovery, samples were processed 
under sterile conditions. Before starting the cell isolation proce-
dure, sterility controls on the adipose tissue were performed by 
using specific bacterial and fungi media such as Blood-Agar, Plate 
Count Agar (PCA) e Agar Sabouraud to be sure that no contami-
nation events occurred during the sampling.  
First of  all adipose tissue sample was washed extensively (about 3 
times) with HBSS enriched of  2% a penicillin-streptomycin in or-
der to remove debris and blood. The piece was then weighed and 
placed in 90 mm petri plates with 15-20 ml of  penicillin-strep-
tomycin enriched saline solution to be mechanically fragmented 
into small pieces and subjected to further washes with the saline 
solution.
Fragmented sample was then placed in a flask with a solution of  
0.2% collagenase type IA in PBS (20 ml of  collagenase per gram 
of  adipose tissue to digest) supplemented with 1% antibiotics 
(penicillin, streptomycin and amphotericin) . Enzymatic digestion 
was performed in thermostatic bath at 37°C under stirring for 2-3 
hours until the complete disruption of  the extracellular matrix 
and the release of  the cellular fraction.
Standard cell culture medium consisting of  Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% FBS and 1% 
penicillin-streptomycin was then added for neutralizing the activ-
ity of  the enzyme.
The digested tissue was filtered with a sterile gauze, placed in 50 
ml tubes and centrifuged at 2700g for 10 minutes at room tem-
perature.
The supernatantwas therefore aspirated and the cell pellet ob-
tained was resuspended in 10 ml of  complete medium (Dulbecco 
low glucose + 20% SFB + 1% antibiotic-antimycotic), centri-
fuged 2 times at 1400g for 10 minutes at room temperature to 
remove any residual enzymatic solution.
After spinning, cell suspension was resuspended in 10 ml of  com-
plete medium, filtered through a cell strainer (pore size 70 µm) 
and centrifuged. Sterility controls were performed again as de-
scribed above to be sure that no contamination events occurred 
during the isolation procedure.
Cell suspension obtained was added with 3ml of  DMEM and 
cells were counted in a Burker Camera by using Trypan Blue. Cells 
were then plated in 25 cm2  culture flasks in DMEM-Low Glu-
cose medium supplemented with glutamine, foetal bovine serum 
(FBS) and 1% penicillin-streptomycin. Cultures were maintained 
in an incubator with an humidified atmosphere containing 5% 
CO2. The CO2 incubator has a constant temperature of  37°C, 
ideal for human and animal cells, and a relative humidity of  100 
% to prevent evaporation of   culture medium.
Medium was changed after 48h incubation in order to remove the 
non-adherent fraction, consisting of  hematopoietic cells, debris 
and other cell types not able to adhere to the plastic. 
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When cells reached 80% confluence, subcultures were performed 
by using trypsine-EDTA enzyme to remove adherent cells from 
the flask.
The identity of  AD-MSCs was verified by their ability to attach to 
the plastic surface of  culture flasks, form CFU (colony-forming 
units) and differentiate into cells of  mesodermal lineages: chon-
drocytes, adipocytes and osteocytes. The presence of  transcrip-
tion factors indicative of  self-renewal and undifferentiation was 
also investigated.
CFU Assay
The colony forming efficiency on plastic was assayed by plating 
isolated cells at three different seeding densities (150, 60 and 30 
cells/cm2) in 6-well plates in DMEM Low Glucose with 5% FBS. 
Cells were incubated for 2 weeks in an incubator with humidified 
air and 5% CO2. The colonies were stained with Giemsa solution 
and scored.
Differentiation of  AD-MSCs (Osteogenesis, Chondrogen-
esis And Adipogenesis)
Cells derived from subcutaneous and visceral fat and expanded in 
the DMEM Low Glucose medium with 20% FBS were used for 
differentiation studies. The MSCs were cultured in appropriate 
differentiation media to obtain the 3 mesodermal lineages (osteo-
genic, chondrogenic and adipogenic). All studies were carried out 
with the same number of  controls.
Osteogenesis
Cells were plated at 4500 cells/cm2 on 6-well plates and treated 
with NH OsteoDiff  Medium (Mylteny Biotec) for 3 weeks, with 
a medium change once every 3 days. von Kossa staining was used 
to detect calcified extracellular matrix deposits.
Chondrogenesis
Micromass cultures of  cells (1×106 cells/ml) were incubated in 15 
ml test tubes with NH Chondro Diff  Medium (Mylteny Biotec) 
for 30 days, with a medium change once every 3 days. The micro-
masses were fixed and stained with hematoxylin-eosin
Adipogenesis
Cells were plated at 7500 cells/cm2 on 6-well plates, and treated 
with Complete MesenCult Adipogenic Medium (Stemcell Tech-
nologies) for 21 days with a medium change once every 3 days. 
Oil Red O staining was used to examine lipid droplet formation.
Results and Discussion
Isolation and Culture of  Mesenchymal Stem Cells from Adi-
pose Tissue
MSCs were successfully isolated from adipose tissue; they reached 
the semiconfluence (80%) in 25 cm2 flasks in 5-6 days, maintain-
ing the typical fibroblastoid appearance. We were able to obtain 
a significant amount of  cells (3x106) in 5-6 days from a single 
adipose tissue sample.Subcultures were made until it was possible 
to observe the maintenance of  the characteristic phenotype and 
appreciable levels of  vitality in culture. For some samples, it was 
possible to observe cell growth up to the tenth passage, the other 
samples were observed until the fifth subculture.
Microbiological Controls
The microbiological controls, performed on the samples of  adi-
pose tissue and on cells performed after the extraction protocol, 
were negative for contamination by bacteria and fungi. It has 
therefore confirmed that the tissue procurement and handling of  
cell cultures were performed under sterile conditions.
MSCs Characterization
CFU Assay
The clonogenic assay for testing the efficiency of  the cells in cul-
ture was performed on all samples at cell passages 1, 3, 5. Results 
obtained demonstrated that MSCs maintain clonogenic ability 
(figure 1).
Differentiation of  MSCs.
MSCs isolated show differentiation capacity towards the three 
mesodermal cell lines osteocitic, adipocytic, condrociti.
Osteogenesis
MSCs cultured in OsteoDiff  Medium showed cuboidal pheno-
type, continue to actively proliferate and form cell aggregates. Af-
ter "von Kossa" staining on cells induced to differentiate, it was 
notable the deposition of  calcified extracellular matrix, displayed 
in black, derived from the precipitation of  silver salts (figure 2). In 
control cells, coltured with maintenance medium, the phenotype 
did not change.
Condrogenesis
The formation of  three-dimensional aggregates was observed in 
the tubes in conical bottom containing NH ChondroDiff  Me-
dium, (figure 2a) but not in control tubes with the same concen-
tration of  cells in maintenance medium.
The hematoxylin-eosin staining, performed on sections of  the 
nodule fixed to the slide, showed that cells acquired a structural 
organization similar to that of  cartilage (figure 2b).
Adipogenesis
After 4-5 days, MSCs cultured in Adipogenic Medium with Mes-
enCult, formed numerous lipid accumulation in the cytoplasm 
(figure 3a). The increase in size of  the lipid droplets was verified 
in subsequent observations. At day 21 after induction of  differ-
entiation Oil Red O and hematoxylin staining was performed to 
highlight the cell nuclei in blue and fat deposits in red (figure 3b). 
No differentiation was observed in control cells (figure 3c).
Mesenchymal stem cells isolated from adipose tissue show high 
proliferative potential in culture and ability to differentiate into 
different cell types. Adipose tissue is almost ubiquitously distrib-
uted, the levy provides minimally invasive techniques and is a 
source of  stem cells phenotypically comparable to bone marrow 
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MSCs, until now reputed the best source of  choice for the supply 
of  autologous stem cells. 
In this work, we studied the characteristics of  MSCs isolated from 
subcutaneous adipose tissue of  Wistar rats. Cells were character-
ized by assessing the adherence to the plastic material, the fibro-
blast-like morphology, the clonogenic potential and the differen-
tiation potential in mesodermal cell lines. MSCs isolated retain 
their typical fibroblastoid morphology and constant proliferation 
for at least 5 passages in basal culture medium. 
The aim of  this study, approved and granted by Italian Board of  
Health, was to isolate and characterize rat Adipose Derived Mes-
enchymal Stem Cells (AD-MSCs) in order to evaluate their prolif-
erative potential and their ability to differentiate into different cell 
types [16]. This first characterization is essential for the second 
part of  our study in which we are planning to use AD-MSCs in 
vivo to restore renal function after an induced ischemic damage in 
experimental animals [17]. Acute renal failure is a medical emer-
gency; in Italy about 5 millions people are affected and there are 
10.000 new cases every year. This disease is mostly caused by a 
damage of  endothelial cells of  the kidney which inhibits reperfu-
sion and  restoring of  organ function. After an ischemic offense, 
Endothelial Progenitor Cells (EPCs) move from Bone Marrow 
(BM) to the damaged site [18]. However, subjects affected by 
chronic renal failure, have lost the regenerative ability of  their kid-
ney progenitor cells and of  their BM which become aplastic [19]. 
For this reason it is important to find alternative sources of  cells 
able to restore the damaged site and we are going to investigate 
the role of  AD-MSCs.
As the future goal of  the study is to use these cells in vivo, we 
wanted to test if  it is possible to get an adequate amount of  cells, 
with characteristics of  stem cell, to avoid any mutations or al-
terations gene that may occur to proceed subcultures. Since the 
retrieval does not require the sacrifice of  the animal, it can be 
concluded that the subcutaneous adipose tissue is preferable es-
pecially for the later stages of  the in vivo study in which each 
animal could receive autologous MSCs. The possibility of  using 
these cells in the field of  cell therapy and regenerative medicine 
  Figure 1. (a) Colony generated by isolated MSCs. 5X magnification, Von Kossa staining of  MSCs maintained in NH Oste-
oDiff  Medium for 21 days. (b) 5X magnification (c) 10X magnification. Black spots represent silver salts precipitation.
Figure 2. (a) formation of  three-dimensional aggregates in the tubes in conical bottom containing NH ChondroDiff  Me-
dium (b) hematoxylin-eosin staining, performed on sections of  the nodule fixed to the slide at 5X magnification and c) 20X 
magnification.
Figure 3. (a) lipid accumulation in the MSCs cytoplasm after 4-5 culture in Adipogenic Medium with MesenCult (b) Oil 
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is reinforced by the fact that a significant number of  cells can be 
obtained and that their use does not involve any kind of  ethical 
or legal. The three-dimensional growth of  these cells on scaffolds 
could be the challenge for the future to rebuild organs and tissues 
in the laboratory. [20-29]. 
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